Wellnex Life Limited
WNX.AX
Australian Securities Exchange0.06
AUD
- -
- -
Wellnex Life Limited
WNX.AX
(Australian Securities Exchange)
Recent
price
0.06
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Wellnex Life Limited is an Australian consumer healthcare company specializing in the development, licensing, marketing, and distribution of health and wellness products. The company’s product portfolio includes topical anti-inflammatory creams, sprays, roll-ons, and heat patches under the Pain Away brand, as well as dietary supplements and liquid soft gel analgesics distributed under brands such as Wakey Wakey, Nighty Night, Pharmacy Own, The Iron Company, and Mr Bright. Wellnex Life holds Therapeutic Goods Administration (TGA) registrations for various pharmaceutical formulations and has intellectual property licensing agreements with Haleon and Arrotex. Its products are distributed through pharmacy wholesalers, major retail chains including Chemist Warehouse, Woolworths, and Coles, as well as independent pharmacies across Australia and New Zealand, with expanding operations into the UK and UAE markets. Founded in 2001 and headquartered in Australia, Wellnex Life has recently undergone transformative business expansions, including the December 2023 acquisition of the Pain Away brand, a leading Australian topical pain relief product. The company has entered strategic joint ventures with OneLife Botanical and Chemist Warehouse to develop and distribute SAS-B designated over-the-counter medicinal cannabis products under the Wellness Life brand, and to market Wagner Health Liquigesic. Wellnex Life has also launched a wholly owned digital sales channel and e-commerce platform to distribute newly branded health and wellness products. In 2024, Wellnex Life received its first purchase order for the UK market and expanded agreements with Haleon to increase product ranges and international launches, reinforcing its position in domestic and international healthcare markets. Wellnex Life’s recent capital raising initiatives, supported by Salter Brothers Capital, have been directed towards accelerating growth in medicinal cannabis products and expanding its health and wellness digital platform. The company is focused on driving profitability through operational efficiencies while scaling its manufacturing partnerships and expanding its geographical footprint internationally. This strategic evolution positions Wellnex Life as a significant player in the Australasian and global consumer health and wellness industry with a diversified product portfolio and expanding market presence.